Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies

The monoclonal antibodies (mAbs) have significantly changed the treatment of multiple myeloma (MM) patients. However, despite their introduction, MM remains an incurable disease. The mAbs currently used for MM treatment were developed with different mechanisms of action able to target antigens, such...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Storti, Paola, Costa, Federica, Marchica, Valentina, Burroughs-Garcia, Jessica, dalla Palma, Benedetta, Toscani, Denise, Eufemiese, Rosa Alba, Giuliani, Nicola
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564331/
https://ncbi.nlm.nih.gov/pubmed/32899714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092864
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars